5 Things California: Gene therapy, Statewide HIE, Kaiser protests
Eli Kirshbaum | Nov 18, 2021 | California
Eli Kirshbaum | Nov 18, 2021 | California
Eli Kirshbaum | Nov 17, 2021 | California
Eli Kirshbaum | Nov 1, 2021 | California
Aaron Kunkler | Oct 26, 2021 | Washington
Bhash Parasuraman, vice president of value and access for rare disease and internal medicine at Pfizer, joined State of Reform on Thursday for a conversation on the future of gene therapy. As part of our virtual “Leadership Series,” Parasuraman discussed the outlook for gene therapy, the policies she’d like to
A new study suggests that people with rare diseases face much higher health care costs than those without a rare disease. The study was led by the National Institute of Health and published on Oct. 21. It found that over a 15 year period, the cost per patient per year